TSX Venture Exchange: NVC VANCOUVER, May 24, 2012 /PRNewswire/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular disease, today announced

KIRKLAND, Wash., May 21, 2012 /PRNewswire/ -- Cardiac Dimensions®,( )Inc.

NATICK, Mass., May 15, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus(TM)

--Presentations will Highlight Promising Results from Animal Studies-- TSX Venture Exchange: NVC VANCOUVER, May 14, 2012 /PRNewswire/ - Neovasc

Patients with mitral regurgitation, a type of valvular heart disease common in the elderly, are living longer after surgery.